Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan (vol 36, pg 134, 2013)

Correction to: Hypertension Research (2013) 36, 134–139; doi:10.1038/hr.2012.147; published online 4 October 2012 After the publication of this article, the authors noticed an error in Figure 2. The asterisk (*) was missing from the bar labeled ‘Azilsartan’ in the WT receptor group. The correct figure is shown below.